Cargando…
Targeting hypoxia in solid and haematological malignancies
Tumour hypoxia is a known and extensively researched phenomenon that occurs in both solid and haematological malignancies. As cancer cells proliferate, demand for oxygen can outstrip supply reducing tumour oxygenation. In solid tumours this is contributed to by disorganized blood vessel development....
Autores principales: | Harris, Bill, Saleem, Sana, Cook, Natalie, Searle, Emma |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9628170/ https://www.ncbi.nlm.nih.gov/pubmed/36320041 http://dx.doi.org/10.1186/s13046-022-02522-y |
Ejemplares similares
-
The hypoxia signalling pathway in haematological malignancies
por: Irigoyen, Marta, et al.
Publicado: (2017) -
Targeting Metabolism and Autophagy in the Context of Haematologic Malignancies
por: Banerji, Versha, et al.
Publicado: (2012) -
Cancer Chemotherapy—Its role in the Treatment Strategy of Haematologic Malignancies and Solid Tumours
por: Crowther, D.
Publicado: (1977) -
Improving TCR Gene Therapy for Treatment of Haematological Malignancies
por: Nicholson, Emma, et al.
Publicado: (2012) -
Tuberculosis in Patients with Haematological Malignancies
por: Anibarro, Luis, et al.
Publicado: (2014)